Next Generation Sequencing (NGS) Tests – Pipeline Products by Stage of Development 20
Next Generation Sequencing (NGS) Tests – Pipeline Products by Territory 21
Next Generation Sequencing (NGS) Tests – Pipeline Products by Regulatory Path 22
Next Generation Sequencing (NGS) Tests – Pipeline Products by Estimated Approval Date 23
Next Generation Sequencing (NGS) Tests – Ongoing Clinical Trials 24
Next Generation Sequencing (NGS) Tests Companies – Pipeline Products by Stage of Development 25
Next Generation Sequencing (NGS) Tests – Pipeline Products by Stage of Development 29
4bases SA Pipeline Products & Ongoing Clinical Trials Overview 34
BRaVO Screen – Product Status 34
BRaVO Screen – Product Description 35
AccuraGen Inc Pipeline Products & Ongoing Clinical Trials Overview 36
Firefly – Product Status 36
Firefly – Product Description 36
ACT Genomics Co LTD Pipeline Products & Ongoing Clinical Trials Overview 37
ACTSpot NTRK Test – Product Status 37
ACTSpot NTRK Test – Product Description 37
Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview 38
ClonoSEQ Assay – Non-Hodgkin’s Lymphoma – Product Status 38
ClonoSEQ Assay – Non-Hodgkin’s Lymphoma – Product Description 39
Almac Diagnostic Services Ltd Pipeline Products & Ongoing Clinical Trials Overview 40
Next-Generation Sequencing Based Companion Diagnostic Assay – Product Status 40
Next-Generation Sequencing Based Companion Diagnostic Assay – Product Description 40
Pan-Cancer Companion Diagnostic Assay – Product Status 41
Pan-Cancer Companion Diagnostic Assay – Product Description 41
Amoy Diagnostics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 42
AmoyDx LC10-Essential NGS Panel – Product Status 42
AmoyDx LC10-Essential NGS Panel – Product Description 42
AnchorDx Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 43
NGS-Based Multi-Cancer Screening Test – Product Status 43
NGS-Based Multi-Cancer Screening Test – Product Description 43
NGS-Based Pan-Cancer Panel – Product Status 44
NGS-Based Pan-Cancer Panel – Product Description 44
NGS-Based Single-Cancer Screening Test – Product Status 44
NGS-Based Single-Cancer Screening Test – Product Description 45
PulmoSeek Plus – Product Status 45
PulmoSeek Plus – Product Description 45
ArcherDx Inc Pipeline Products & Ongoing Clinical Trials Overview 46
AMP-Based Assay – Cancer – Product Status 46
AMP-Based Assay – Cancer – Product Description 46
NextSeq 550Dx System – Blood Cancer CDx Assay – Product Status 47
NextSeq 550Dx System – Blood Cancer CDx Assay – Product Description 47
NextSeq 550Dx System – Minimal Residual Disease Assay – Product Status 47
NextSeq 550Dx System – Minimal Residual Disease Assay – Product Description 48
NextSeq 550Dx System – Solid Tumor CDx Assay – Product Status 48
NextSeq 550Dx System – Solid Tumor CDx Assay – Product Description 48
NGS-Based Companion Diagnostic Assay – Cancer – Product Status 49
NGS-Based Companion Diagnostic Assay – Cancer – Product Description 49
Berry Oncology Corp Pipeline Products & Ongoing Clinical Trials Overview 50
Lai Si Ning – Product Status 50
Lai Si Ning – Product Description 50
BGI Genomics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 51
SENTIS Colorectal Cancer Panel – Liquid Biopsy Version – Product Status 51
SENTIS Colorectal Cancer Panel – Liquid Biopsy Version – Product Description 51
Biocartis Group NV Pipeline Products & Ongoing Clinical Trials Overview 52
Idylla NGS Prep Panel – Lung – Product Status 52
Idylla NGS Prep Panel – Lung – Product Description 52
Idylla Retrieve – NGS Hotspot Panel Assay – Product Status 53
Idylla Retrieve – NGS Hotspot Panel Assay – Product Description 53
Biodesix Inc Pipeline Products & Ongoing Clinical Trials Overview 54
52-Gene Panel Based Companion Diagnostic – Product Status 54
52-Gene Panel Based Companion Diagnostic – Product Description 54
TAm-Seq NGS Lung Cancer Test – Product Status 55
TAm-Seq NGS Lung Cancer Test – Product Description 55
BioLink Pipeline Products & Ongoing Clinical Trials Overview 56
Diagnostic Test – Breast Cancer – Product Status 56
Diagnostic Test – Breast Cancer – Product Description 56
bioTheranostics Inc Pipeline Products & Ongoing Clinical Trials Overview 57
CancerTREATMENT ID – Product Status 57
CancerTREATMENT ID – Product Description 57
Boston University Pipeline Products & Ongoing Clinical Trials Overview 58
Diagnostic Test – Esophageal Adenocarcinoma – Product Status 58
Diagnostic Test – Esophageal Adenocarcinoma – Product Description 58
Buhlmann Laboratories AG Pipeline Products & Ongoing Clinical Trials Overview 59
NGS Targeted Hotspot Panel 16 Kit – Product Status 59
NGS Targeted Hotspot Panel 16 Kit – Product Description 60
Burning Rock Biotech Ltd Pipeline Products & Ongoing Clinical Trials Overview 61
OncoCompass Target CDx Test – Tepotinib – Product Status 61
OncoCompass Target CDx Test – Tepotinib – Product Description 62
OverC Multi-Cancer Detection Blood Test Kit – Product Status 62
OverC Multi-Cancer Detection Blood Test Kit – Product Description 62
Burning Rock Biotech Ltd – Ongoing Clinical Trials Overview 63
OverC Multi-Cancer Detection Blood Test Kit – A Prospective Multi-cancer Early-detection and Interventional Study in Asymptomatic Individuals: PREVENT 64
OverC Multi-Cancer Detection Blood Test Kit – A Prospective, Multicenter Study on Development and Validation of the Performance of a cfDNA Methylation-based Model for Early Cancer Detection (Pan-cancer Early Detection project, PREDICT Study) 64
OverC Multi-Cancer Detection Blood Test Kit – Assessment of Early Detection and Prognosis Based on cfDNA Methylation in Myeloma: a Proof of Concept Study 64
OverC Multi-Cancer Detection Blood Test Kit – Assessment of Early Detection Based on Liquid Biopsy in Intracranial Tumors: a Prospective Observational Study 65
OverC Multi-Cancer Detection Blood Test Kit – Burning Rock Pan-cancer Early Detection Project (PREDICT): A Prospective, Multicenter Study to Develop and Validate the Performance of a Cfdna Methylation Based Model on Early Cancer Detection 65
OverC Multi-Cancer Detection Blood Test Kit – Early Detection of Primary Liver Cancer Based on cfDNA Methylation: A Multi-Center Case-Control Study (PRIMe-liver) 65
OverC Multi-Cancer Detection Blood Test Kit – Gynecological Malignancies Earlystage Detection by Multi-omics Based Liquid Biopsy in Peripheral Blood: a Prospective, Extended Validation Study 66
OverC Multi-Cancer Detection Blood Test Kit – Pan-cancer Early-stage Detection by Liquid Biopsy in Peripheral Blood: A Multi-center, Prospective Observational Study 66
Cardiff Oncology Inc Pipeline Products & Ongoing Clinical Trials Overview 67
Mutation Enrichment Kit – Product Status 67
Mutation Enrichment Kit – Product Description 67
Cerba HealthCare SAS Pipeline Products & Ongoing Clinical Trials Overview 68
Diagnostic Test – Cancer – Product Status 68
Diagnostic Test – Cancer – Product Description 68
DCGen Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 69
HOPE – Product Status 69
HOPE – Product Description 69
OncoFREE – Product Status 70
OncoFREE – Product Description 70
Eiken Chemical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 71
Companion Diagnostic Kit – Non-Small Cell Lung Cancer – Product Status 71
Companion Diagnostic Kit – Non-Small Cell Lung Cancer – Product Description 71
Epic Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 72
DefineMBC – Product Status 72
DefineMBC – Product Description 72
Epigenomics AG Pipeline Products & Ongoing Clinical Trials Overview 73
NGS Panel – Bladder Cancer – Product Status 73
NGS Panel – Bladder Cancer – Product Description 73
NGS Panel – Breast Cancer – Product Status 74
NGS Panel – Breast Cancer – Product Description 74
NGS Panel – Colon Cancer – Product Status 74
NGS Panel – Colon Cancer – Product Description 75
NGS Panel – Lung Cancer – Product Status 75
NGS Panel – Lung Cancer – Product Description 75
NGS Panel – Ovarian Cancer – Product Status 76
NGS Panel – Ovarian Cancer – Product Description 76
NGS Panel – Prostate Cancer – Product Status 76
NGS Panel – Prostate Cancer – Product Description 77
First Genetics JCS Pipeline Products & Ongoing Clinical Trials Overview 78
F-Genetics NGS System – Oncology – Product Status 78
F-Genetics NGS System – Oncology – Product Description 78
Flomics Biotech Pipeline Products & Ongoing Clinical Trials Overview 79
Colon Cancer Diagnostic Test – Product Status 79
Colon Cancer Diagnostic Test – Product Description 79
Lung Cancer Diagnostic Test – Product Status 80
Lung Cancer Diagnostic Test – Product Description 80
Foundation Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview 81
FoundationOne CDx – BI 907828 – Product Status 81
FoundationOne CDx – BI 907828 – Product Description 82
FoundationOne CDx – Vitrakvi – Product Status 82
FoundationOne CDx – Vitrakvi – Product Description 82
Freenome Inc Pipeline Products & Ongoing Clinical Trials Overview 83
Artificial Intelligence Based Companion Diagnostics – Colorectal Cancer – Product Status 83
Artificial Intelligence Based Companion Diagnostics – Colorectal Cancer – Product Description 83
Freenome Inc – Ongoing Clinical Trials Overview 84
Artificial Intelligence Based Companion Diagnostics – Colorectal Cancer – Prevention of Colorectal Cancer Through Multiomics Blood Testing 85
Artificial Intelligence Based Companion Diagnostics – Colorectal Cancer – The Vallania Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening 85
Gencurix Inc Pipeline Products & Ongoing Clinical Trials Overview 86
NGS (Next Generation Sequencing) Cancer Test – Product Status 86
NGS (Next Generation Sequencing) Cancer Test – Product Description 86
GeneCast Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 87
Genecast IVD – Comprehensive – Product Status 87
Genecast IVD – Comprehensive – Product Description 88
Genecast IVD – ctDNA Focus – Product Status 88
Genecast IVD – ctDNA Focus – Product Description 89
Genecast IVD – Early Detection Multi-Cancer – Product Status 89
Genecast IVD – Early Detection Multi-Cancer – Product Description 90
Genecast IVD – KNBP – Melanoma – Product Status 90
Genecast IVD – KNBP – Melanoma – Product Description 90
Genecast IVD – MammaPrint – Product Status 91
Genecast IVD – MammaPrint – Product Description 91
Genecast IVD – MRD Solid Tumors – Product Status 91
Genecast IVD – MRD Solid Tumors – Product Description 92
Genecast IVD – RNA Fusion Focus – Product Status 92
Genecast IVD – RNA Fusion Focus – Product Description 93
Geneseeq Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 94
Comprehensive Cancer NGS Diagnostic Kit – Product Status 94
Comprehensive Cancer NGS Diagnostic Kit – Product Description 94
Genetron Health (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 95
Blood-Based Lung EGFR NGS IVD Assay – Product Status 95
Blood-Based Lung EGFR NGS IVD Assay – Product Description 95
Genomic Health Inc Pipeline Products & Ongoing Clinical Trials Overview 96
Liquid Biopsy-Based Bladder Cancer Test – Product Status 96
Liquid Biopsy-Based Bladder Cancer Test – Product Description 96
Next Generation Sequencing Oncotype DX – Prostate Cancer Assay – Product Status 97
Next Generation Sequencing Oncotype DX – Prostate Cancer Assay – Product Description 97
GigaGen Inc Pipeline Products & Ongoing Clinical Trials Overview 98
GigaMune HemeOnc – Product Status 98
GigaMune HemeOnc – Product Description 98
HaploX Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 99
HaploX AiScreening Pan-cancer Early Screening Testing Kit – IVD – Product Status 99
HaploX AiScreening Pan-cancer Early Screening Testing Kit – IVD – Product Description 100
HaploX AiScreening Pan-cancer Early Screening Testing Kit – LDT – Product Status 100
HaploX AiScreening Pan-cancer Early Screening Testing Kit – LDT – Product Description 100
HaploX PulmoScope Pulmonary Nodule Diagnosis Testing Kit – IVD – Product Status 101
HaploX PulmoScope Pulmonary Nodule Diagnosis Testing Kit – IVD – Product Description 101
HaploX PulmoScope Pulmonary Nodule Diagnosis Testing Kit – LDT – Product Status 101
HaploX PulmoScope Pulmonary Nodule Diagnosis Testing Kit – LDT – Product Description 102
HaploX UrineScope Urological Tumor Screening Testing Kit – IVD – Product Status 102
HaploX UrineScope Urological Tumor Screening Testing Kit – IVD – Product Description 102
HaploX UrineScope Urological Tumor Screening Testing Kit – LDT – Product Status 103
HaploX UrineScope Urological Tumor Screening Testing Kit – LDT – Product Description 103
HapOnco PharmCDx NGS Testing Kit – Product Status 103
HapOnco PharmCDx NGS Testing Kit – Product Description 104
HapOnco WESPlus NGS Testing Kit – Pan Cancer – Product Status 104
HapOnco WESPlus NGS Testing Kit – Pan Cancer – Product Description 104
Haystack Oncology Inc Pipeline Products & Ongoing Clinical Trials Overview 105
MRD Test – Breast Cancer – Product Status 105
MRD Test – Breast Cancer – Product Description 105
MRD Test – Colorectal Cancer – Product Status 106
MRD Test – Colorectal Cancer – Product Description 106
MRD Test – Lung Cancer – Product Status 106
MRD Test – Lung Cancer – Product Description 107
HTG Molecular Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 108
CNV Navigator – Product Status 108
CNV Navigator – Product Description 109
Ion PGM Dx System – Cancer Assay – Product Status 109
Ion PGM Dx System – Cancer Assay – Product Description 109
Illumina Inc Pipeline Products & Ongoing Clinical Trials Overview 110
Companion Diagnostic Test – Oncology – Product Status 110
Companion Diagnostic Test – Oncology – Product Description 111
TruSight Oncology 500 – TP53 CDx Assay – Product Status 111
TruSight Oncology 500 – TP53 CDx Assay – Product Description 111
TruSight Oncology 500 HRD – Product Status 112
TruSight Oncology 500 HRD – Product Description 112
TruSight Oncology Comprehensive – Product Status 112
TruSight Oncology Comprehensive – Product Description 113
TruSight Tumor 170 CDx – LOXO-101 – Product Status 113
TruSight Tumor 170 CDx – LOXO-101 – Product Description 113
TruSight Tumor 170 CDx – LOXO-292 – Product Status 114
TruSight Tumor 170 CDx – LOXO-292 – Product Description 114
Illumina Inc – Ongoing Clinical Trials Overview 115
TruSight Oncology Comprehensive – A Study to Examine the Clinical Value of Comprehensive Genomic Profiling Performed by Belgian NGS Laboratories: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Centre – Belgian Approach for Local Laboratory Extensive Tumor Testing (BALLETT) 116
TruSight Oncology 500 HRD – Molecular Landscape Involved in the Onset of Breast Cancer in Patients With Germline BRCA-1/2 Mutations, During or After Therapy With Platinum-based Agents and/or PARP-inhibitors for Ovarian Cancer 117
Immunovia AB Pipeline Products & Ongoing Clinical Trials Overview 118
ProMIS Assay – Product Status 118
ProMIS Assay – Product Description 118
Inivata Ltd Pipeline Products & Ongoing Clinical Trials Overview 119
InVision ctDNA Assay – EGFR-Mutant NSCLC – Product Status 119
InVision ctDNA Assay – EGFR-Mutant NSCLC – Product Description 120
InVision ctDNA Assay – Metastatic Breast Cancer – Product Status 120
InVision ctDNA Assay – Metastatic Breast Cancer – Product Description 120
InVision ctDNA Assay – NSCLC – Product Status 121
InVision ctDNA Assay – NSCLC – Product Description 121
InVision ctDNA Assay – Pancreatic Cancer – Product Status 121
InVision ctDNA Assay – Pancreatic Cancer – Product Description 122
InVision ctDNA Assay – Stage III/IV NSCLC – Product Status 122
InVision ctDNA Assay – Stage III/IV NSCLC – Product Description 122
RaDaR Assay – Product Status 123
RaDaR Assay – Product Description 123
Inivata Ltd – Ongoing Clinical Trials Overview 124
RaDaR Assay – Liquid Biopsy for Minimal Residual Disease Detection in Head and Necksquamous Cell Carcinoma (LIONESS) Study 125
RaDaR Assay – SURVIVE (Standard Surveillance vs. Intensive Surveillance in Early Breast Cancer) – a Partially Double-blinded, Multi-center, Randomized, Controlled Superiority Study 125
Insight Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 126
NGS Lung Panel Test – Product Status 126
NGS Lung Panel Test – Product Description 126
InVivoScribe Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 127
B-cell Immuno-Oncology Assay Kit – Product Status 127
B-cell Immuno-Oncology Assay Kit – Product Description 128
LymphoTrack Dx TRB Assay – PGM – Product Status 128
LymphoTrack Dx TRB Assay – PGM – Product Description 128
MiSeqDx – Cancer Diagnostic Test – Product Status 129
MiSeqDx – Cancer Diagnostic Test – Product Description 129
NGS Based Hematologic Malignancy Test – Product Status 129
NGS Based Hematologic Malignancy Test – Product Description 130
T-cell Immuno-Oncology Assay Kit – Product Status 130
T-cell Immuno-Oncology Assay Kit – Product Description 130
IvyGene Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 131
IvyGene Test – Brain Cancer – Product Status 131
IvyGene Test – Brain Cancer – Product Description 131
IvyGene Test – Breast Cancer – Product Status 132
IvyGene Test – Breast Cancer – Product Description 132
IvyGene Test – Colorectal Cancer – Product Status 132
IvyGene Test – Colorectal Cancer – Product Description 133
IvyGene Test – Lung Cancer – Product Status 133
IvyGene Test – Lung Cancer – Product Description 133
IvyGene Test – Nasopharyngeal Carcinoma – Product Status 134
IvyGene Test – Nasopharyngeal Carcinoma – Product Description 134
IvyGene Test – Ovarian Cancer – Product Status 134
IvyGene Test – Ovarian Cancer – Product Description 135
IvyGene Test – Pancreatic Cancer – Product Status 135
IvyGene Test – Pancreatic Cancer – Product Description 135
Laboratory Corp of America Holdings Pipeline Products & Ongoing Clinical Trials Overview 136
IntelliGEN Myeloid Test – Product Status 136
IntelliGEN Myeloid Test – Product Description 137
Leto Laboratories Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 138
Companion Diagnostic Test – Solid Tumors – Product Status 138
Companion Diagnostic Test – Solid Tumors – Product Description 138
Prognostic Test – Solid Tumor Immunotherapy – Product Status 139
Prognostic Test – Solid Tumor Immunotherapy – Product Description 139
Lucence Diagnostics Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 140
Lymphoma Subtype Test – Product Status 140
Lymphoma Subtype Test – Product Description 140
MedySapiens Inc Pipeline Products & Ongoing Clinical Trials Overview 141
NEOseq_Cancer – Product Status 141
NEOseq_Cancer – Product Description 141
Mega Genomics Ltd Pipeline Products & Ongoing Clinical Trials Overview 142
BRCA1/BRCA2 Gene Mutation Diagnostic Kit – Product Status 142
BRCA1/BRCA2 Gene Mutation Diagnostic Kit – Product Description 142
Cervical Cancer Screening Kit – Product Status 143
Cervical Cancer Screening Kit – Product Description 143
Colorectal Cancer Screening Kit – Product Status 143
Colorectal Cancer Screening Kit – Product Description 144
Gastric Cancer Screening Kit – Product Status 144
Gastric Cancer Screening Kit – Product Description 144
Lung Nodule Auxiliary Diagnostic Kit – Product Status 145
Lung Nodule Auxiliary Diagnostic Kit – Product Description 145
MolecularMD Corp Pipeline Products & Ongoing Clinical Trials Overview 146
NGS Assay – Lung Cancer – Product Status 146
NGS Assay – Lung Cancer – Product Description 146
Notch1 NGS Test – Chronic Lymphocytic Leukemia – Product Status 147
Notch1 NGS Test – Chronic Lymphocytic Leukemia – Product Description 147
NGeneBio Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 148
BRCA NGS Panel For PARP Inhibitor CDx Test – Product Status 148
BRCA NGS Panel For PARP Inhibitor CDx Test – Product Description 149
LUNGaccuTest – Product Status 149
LUNGaccuTest – Product Description 149
ONCOaccu Panel – Product Status 150
ONCOaccu Panel – Product Description 150
SOLIDaccuCDx SOMATIC – Product Status 150
SOLIDaccuCDx SOMATIC – Product Description 151
SOLIDaccuTest – Product Status 151
SOLIDaccuTest – Product Description 151
Novigenix SA Pipeline Products & Ongoing Clinical Trials Overview 152
LITOSeekColon – Product Status 152
LITOSeekColon – Product Description 152
LITOseekColonMon – Product Status 153
LITOseekColonMon – Product Description 153
LITOSeekProstate – Product Status 153
LITOSeekProstate – Product Description 154
Precision Diagnostic Test – Neuroendocrine Tumor – Product Status 154
Precision Diagnostic Test – Neuroendocrine Tumor – Product Description 154
Novomics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 155
Companion Diagnostic Test – Lung Cancer – Product Status 155
Companion Diagnostic Test – Lung Cancer – Product Description 155
NuGEN Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 156
Epigenetic Test – Cancer – Product Status 156
Epigenetic Test – Cancer – Product Description 156
NuProbe Inc Pipeline Products & Ongoing Clinical Trials Overview 157
Liquid Biopsy NGS Panel – Non-Small Cell Lung Cancer – Product Status 157
Liquid Biopsy NGS Panel – Non-Small Cell Lung Cancer – Product Description 157
Oncodiag Pipeline Products & Ongoing Clinical Trials Overview 158
Prostadiag – Product Status 158
Prostadiag – Product Description 158
OncoDNA SA Pipeline Products & Ongoing Clinical Trials Overview 159
Companion Diagnostic Assay – Tipifarnib – Product Status 159
Companion Diagnostic Assay – Tipifarnib – Product Description 159
OncoSpire Genomics Pipeline Products & Ongoing Clinical Trials Overview 160
Next-Generation Sequencing Test – Lung Cancer – Product Status 160
Next-Generation Sequencing Test – Lung Cancer – Product Description 160
OncXerna Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 161
Xerna TME Companion Diagnostic Assay – Ovarian Cancer – Product Status 161
Xerna TME Companion Diagnostic Assay – Ovarian Cancer – Product Description 161
OrigiMed Inc Pipeline Products & Ongoing Clinical Trials Overview 162
NGS-Based CDx – Larotrectinib – Product Status 162
NGS-Based CDx – Larotrectinib – Product Description 162
Otsuka Medical Devices Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 163
NextSeq 550Dx System – Acute Lymphoblastic Leukemia Assay – Product Status 163
NextSeq 550Dx System – Acute Lymphoblastic Leukemia Assay – Product Description 163
NextSeq 550Dx System – Acute Myeloid Leukemia Assay – Product Status 164
NextSeq 550Dx System – Acute Myeloid Leukemia Assay – Product Description 164
Pasteur Institute Pipeline Products & Ongoing Clinical Trials Overview 165
HPV RNA-Seq Test – Product Status 165
HPV RNA-Seq Test – Product Description 165
Personal Genome Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 166
PGDx elio Plasma Resolve – Product Status 166
PGDx elio Plasma Resolve – Product Description 166
Precision Diagnostics Tool – Product Status 167
Precision Diagnostics Tool – Product Description 167
Pillar Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 168
IVD Onco/Reveal Dx Assay – Blood Cancer – Product Status 168
IVD Onco/Reveal Dx Assay – Blood Cancer – Product Description 168
IVD Onco/Reveal Dx Assay – Liquid Biopsy – Product Status 169
IVD Onco/Reveal Dx Assay – Liquid Biopsy – Product Description 169
IVD Onco/Reveal Dx Assay – Tumor Tissue Testing – Product Status 169
IVD Onco/Reveal Dx Assay – Tumor Tissue Testing – Product Description 170
Predicine Inc Pipeline Products & Ongoing Clinical Trials Overview 171
PredicineCARE Companion Diagnostic Test – Product Status 171
PredicineCARE Companion Diagnostic Test – Product Description 171
Predictive Biosciences Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 172
CertNDx Bladder Cancer Assay – TP53 – Product Status 172
CertNDx Bladder Cancer Assay – TP53 – Product Description 172
Qiagen NV Pipeline Products & Ongoing Clinical Trials Overview 173
Companion Diagnostic Assay – Precancerous Cervical Lesions – Product Status 173
Companion Diagnostic Assay – Precancerous Cervical Lesions – Product Description 174
GeneRead QIAact Lung All-in-One Assay – Product Status 174
GeneRead QIAact Lung All-in-One Assay – Product Description 174
GeneReader NGS System – BRCA Liquid Biopsy Assay – Product Status 175
GeneReader NGS System – BRCA Liquid Biopsy Assay – Product Description 175
GeneReader NGS System – Leukemia – Product Status 175
GeneReader NGS System – Leukemia – Product Description 176
GeneReader NGS System – MPN – Product Status 176
GeneReader NGS System – MPN – Product Description 176
QIAact Breast Panel (Expanded) – Product Status 177
QIAact Breast Panel (Expanded) – Product Description 177
QIAact Lung Panel (CNV And Fusion) – Product Status 177
QIAact Lung Panel (CNV And Fusion) – Product Description 178
QIAact Onco-Heme Panel – Myeloid – Product Status 178
QIAact Onco-Heme Panel – Myeloid – Product Description 178
Quantgene Inc Pipeline Products & Ongoing Clinical Trials Overview 179
DEEPGEN Panel – Product Status 179
DEEPGEN Panel – Product Description 180
Liquid Biopsy Assay – Cancer Recurrence Monitoring – Product Status 181
Liquid Biopsy Assay – Cancer Recurrence Monitoring – Product Description 181
Liquid Biopsy Assay – Minimum Residual Disease – Product Status 181
Liquid Biopsy Assay – Minimum Residual Disease – Product Description 182
Liquid Biopsy Companion Diagnostic Assay – Product Status 182
Liquid Biopsy Companion Diagnostic Assay – Product Description 182
Queen’s University Pipeline Products & Ongoing Clinical Trials Overview 183
Prognostic Tool – ER+ Breast Cancer – Product Status 183
Prognostic Tool – ER+ Breast Cancer – Product Description 183
RealSeq Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 184
RealSeq-SC – Product Status 184
RealSeq-SC – Product Description 184
Rhodx Inc Pipeline Products & Ongoing Clinical Trials Overview 185
Liquid Biopsy Test – Cancer – Product Status 185
Liquid Biopsy Test – Cancer – Product Description 185
Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 186
AVENIO Blood Test – Product Status 186
AVENIO Blood Test – Product Description 186
AVENIO Tissue Test – Product Status 187
AVENIO Tissue Test – Product Description 187
SeqOne SAS Pipeline Products & Ongoing Clinical Trials Overview 188
SeqOne HRD Test – Product Status 188
SeqOne HRD Test – Product Description 188
Silicon Biosystems S.p.A. Pipeline Products & Ongoing Clinical Trials Overview 189
Genomic Cancer Assay – Product Status 189
Genomic Cancer Assay – Product Description 189
Sophia Genetics SA Pipeline Products & Ongoing Clinical Trials Overview 190
Myeloid Solution – Product Status 190
Myeloid Solution – Product Description 190
SOPHiA DDM Dx RNAtarget Oncology Solution – Product Status 191
SOPHiA DDM Dx RNAtarget Oncology Solution – Product Description 191
Spectrum Solutions LLC Pipeline Products & Ongoing Clinical Trials Overview 192
Liquid Biopsy Test – Lung Cancer – Product Status 192
Liquid Biopsy Test – Lung Cancer – Product Description 192
Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview 193
Next Generation Sequencing Based Companion Diagnostic Assay – Product Status 193
Next Generation Sequencing Based Companion Diagnostic Assay – Product Description 193
Sysmex Inostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 194
OncoBEAM – Hepatocellular Carcinoma – Product Status 194
OncoBEAM – Hepatocellular Carcinoma – Product Description 194
Tempus Health Inc Pipeline Products & Ongoing Clinical Trials Overview 195
xT-Onco Assay – Product Status 195
xT-Onco Assay – Product Description 195
Tempus Health Inc – Ongoing Clinical Trials Overview 196
xT-Onco Assay – A Phase 1/2 Study to Evaluate the Safety and Efficacy of A2B530, an Autologous Logic-gated Tmod Chimeric Antigen Receptor T Cell (CAR T), in Heterozygous HLA-A*02 Adult Subjects With Recurrent Unresectable, Locally Advanced, or Metastatic Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression 197
Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 198
Companion Next-Generation Sequencing Oncology Test – Product Status 198
Companion Next-Generation Sequencing Oncology Test – Product Description 199
Next Generation Sequencing Assay – Breast Cancer – Product Status 199
Next Generation Sequencing Assay – Breast Cancer – Product Description 199
Next Generation Sequencing Assay – Pancreatic Cancer – Product Status 200
Next Generation Sequencing Assay – Pancreatic Cancer – Product Description 200
Next Generation Sequencing Assay – Prostate Cancer – Product Status 200
Next Generation Sequencing Assay – Prostate Cancer – Product Description 201
NGS Panel – Pediatric Cancer – Product Status 201
NGS Panel – Pediatric Cancer – Product Description 201
Oncomine Dx Target Test – BLU-667 – Product Status 202
Oncomine Dx Target Test – BLU-667 – Product Description 202
Oncomine Precision Assay – Non-Small Cell Lung Cancer – Product Status 202
Oncomine Precision Assay – Non-Small Cell Lung Cancer – Product Description 203
Oncomine Precision Assay – Solid Tissue Tumor – Product Status 203
Oncomine Precision Assay – Solid Tissue Tumor – Product Description 203
Thermo Fisher Scientific Inc – Ongoing Clinical Trials Overview 204
Oncomine Precision Assay – Non-Small Cell Lung Cancer – A Multi-center Observational Study to Evaluate the Clinical Utility of Returning Genomic Aberration Results Using the Oncomine Precision Assay in Advanced or Metastatic Non-small Cell Lung Cancer within the Exactis Network 205
Trivitron Healthcare Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 206
NGS Based Test – Cancer – Product Status 206
NGS Based Test – Cancer – Product Description 206
NGS Based Test – Infectious Diseases – Product Status 207
NGS Based Test – Infectious Diseases – Product Description 207
NGS Based Test – Prenatal Diseases – Product Status 207
NGS Based Test – Prenatal Diseases – Product Description 208
TwinStrand Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 209
TwinStrand DuplexSeq – Product Status 209
TwinStrand DuplexSeq – Product Description 209
University of Chicago Pipeline Products & Ongoing Clinical Trials Overview 210
Oral Cancer Saliva Test – Product Status 210
Oral Cancer Saliva Test – Product Description 210
University of Michigan Rogel Cancer Center Pipeline Products & Ongoing Clinical Trials Overview 211
UPSeq Test – Product Status 211
UPSeq Test – Product Description 211
University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview 212
Genomic DNA Mutation Assay – Product Status 212
Genomic DNA Mutation Assay – Product Description 212
Vyant Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 213
Cell Free DNA Assay – Kidney Cancer – Product Status 213
Cell Free DNA Assay – Kidney Cancer – Product Description 213
Glossary 284